Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Drug Retailers Should Promote Self-medication: NMRA Meeting
October 7, 2002
- Korosho to Reorganize PFSB
October 7, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 7, 2002
- Mr Miyauchi Criticizes Korosho for Its Opposition to Deregulation
October 7, 2002
- Nippon Keidanren Calls For Simplification of Application for Medical Devices
October 7, 2002
- PFSB to Accelerate Introduction of Fast-Track System
October 7, 2002
- Olympus Sets Up Marketing Subsidiary in Sao Paulo
October 7, 2002
- Drugs for 21st Quality Reevaluation Announced
October 7, 2002
- Olympus: New Reaction/Analysis System FD10
October 7, 2002
- Results of Reexamination for 22 Active Ingredients Announced
October 7, 2002
- Baxter Transfers Cardiovascular Products to Edwards Lifesciences in Japan
October 7, 2002
- DIA Conference on Pharmaceutical Evolution in Asia
October 7, 2002
- New Chugai Inaugurated
October 7, 2002
- Relief of Lower Back Pain Increases Patients' Satisfaction with Osteoporosis Drugs
October 7, 2002
- WORLD NEWS IN BRIEF
October 7, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
October 7, 2002
- ENGLISH BOOK
October 7, 2002
- Maurer's Healthcare Insight (34)
October 7, 2002
- BULLETIN
October 7, 2002
- JP Should Be in Greater Harmony with Pharmacopoeias from Other Countries: Seminar
October 7, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…